Skip to results
Modify your search
NARROW
1-20 of 25
Authors: Olov Wiklund
Journal Article
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning Free
European Journal of Preventive Cardiology, Volume 27, Issue 15, 1 October 2020, Pages 1639–1646, https://doi.org/10.1177/2047487319898951
Published: 01 October 2020
Journal Article
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Free
European Journal of Preventive Cardiology, Volume 23, Issue 11, 1 July 2016, Pages NP1–NP96, https://doi.org/10.1177/2047487316653709
Published: 29 August 2020
Journal Article
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Open Access
European Heart Journal, Volume 41, Issue 24, 21 June 2020, Pages 2313–2330, https://doi.org/10.1093/eurheartj/ehz962
Published: 13 February 2020
Journal Article
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Free
European Heart Journal, Volume 41, Issue 1, 1 January 2020, Pages 111–188, https://doi.org/10.1093/eurheartj/ehz455
Published: 31 August 2019
Journal Article
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract Open Access
European Heart Journal, Volume 39, Issue 27, 14 July 2018, Pages 2526–2539, https://doi.org/10.1093/eurheartj/ehy182
Published: 27 April 2018
Journal Article
New prospects for PCSK9 inhibition? Get access
European Heart Journal, Volume 39, Issue 27, 14 July 2018, Pages 2600–2601, https://doi.org/10.1093/eurheartj/ehy147
Published: 22 March 2018
Journal Article
EDITOR'S CHOICE
New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk Free
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 2, April 2018, Pages 119–127, https://doi.org/10.1093/ehjcvp/pvx031
Published: 28 November 2017
Journal Article
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia Get access
European Heart Journal, Volume 39, Issue 14, 07 April 2018, Pages 1131–1143, https://doi.org/10.1093/eurheartj/ehx549
Published: 16 October 2017
Journal Article
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel Open Access
European Heart Journal, Volume 38, Issue 32, 21 August 2017, Pages 2459–2472, https://doi.org/10.1093/eurheartj/ehx144
Published: 24 April 2017
Journal Article
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk Get access
European Heart Journal, Volume 38, Issue 29, 01 August 2017, Pages 2245–2255, https://doi.org/10.1093/eurheartj/ehw480
Published: 27 October 2016
Journal Article
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias Free
European Heart Journal, Volume 37, Issue 39, 14 October 2016, Pages 2999–3058, https://doi.org/10.1093/eurheartj/ehw272
Published: 28 August 2016
Journal Article
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine Open Access
European Heart Journal, Volume 37, Issue 25, 1 July 2016, Pages 1944–1958, https://doi.org/10.1093/eurheartj/ehw152
Published: 26 April 2016
Journal Article
Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER Free
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 4, October 2016, Pages 212–217, https://doi.org/10.1093/ehjcvp/pvw006
Published: 29 March 2016
Journal Article
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment Open Access
European Heart Journal, Volume 36, Issue 36, 21 September 2015, Pages 2425–2437, https://doi.org/10.1093/eurheartj/ehv157
Published: 25 May 2015
Journal Article
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management Open Access
European Heart Journal, Volume 36, Issue 17, 1 May 2015, Pages 1012–1022, https://doi.org/10.1093/eurheartj/ehv043
Published: 18 February 2015
Journal Article
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society Open Access
European Heart Journal, Volume 35, Issue 32, 21 August 2014, Pages 2146–2157, https://doi.org/10.1093/eurheartj/ehu274
Published: 21 August 2014
Journal Article
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society
Open Access
European Heart Journal, Volume 34, Issue 45, 1 December 2013, Pages 3478–3490, https://doi.org/10.1093/eurheartj/eht273
Published: 15 August 2013
Journal Article
Guidelines on CVD prevention: confusing or complementary? Get access
European Journal of Preventive Cardiology, Volume 20, Issue 1, 1 February 2013, Pages 6–8, https://doi.org/10.1177/2047487312464001
Published: 01 February 2013
Journal Article
GUIDELINES
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Free
European Heart Journal, Volume 33, Issue 13, July 2012, Pages 1635–1701, https://doi.org/10.1093/eurheartj/ehs092
Published: 03 May 2012
Journal Article
GUIDELINES
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Free
European Heart Journal, Volume 32, Issue 14, July 2011, Pages 1769–1818, https://doi.org/10.1093/eurheartj/ehr158
Published: 01 January 2011
